LEADING LIGHT FOR LIFE
The "LEADING LIGHT FOR LIFE" trademark, serial number 79017703 , was filed on 2nd of December 2004 with a mark drawing code of 5000 and its transaction date is 79017703. Since 23rd of January 2014, the document can be found in the M70 law office in the publication and issue section. The employee responsible is MARTIN, JENNIFER MCGAR and the date it was published for opposition on 03/27/2007. The status of this trademark was checked last on 01/23/2014.
The "LEADING LIGHT FOR LIFE" trademark, serial number 79102816 , was filed on 22nd of July 2011 with a mark drawing code of 5000 and its transaction date is 79102816. The attorney assigned is Lawrence E. Abelman, attorney docket number 994991. Since 4th of April 2012, the document can be found in the M40 law office in the publication and issue section. The employee responsible is HESIK, APRIL ANNE and the date it was published for opposition on 06/05/2012. The status of this trademark was checked last on 04/04/2012.
Prior registrations: 3251934
The corresponded responsible for this trademark is Lawrence E. Abelman, located at Abelman Frayne & Schwab, 10th Floor, 666 Third Avenue.The state or country where the trademark was organized is by Astellas Pharma Inc.. The legal entity type behing it is a Corporation, located at Chuo-ku; Tokyo 103-8411, , zip .Other trademarks by this applicant: EYEPRON, RECLOVAN.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 10/10/2011 |
Primary Code | 005 |
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
U.S. Class | 101 - Advertising and Business |
Class Status | 6 - Active |
Status Date | 10/10/2011 |
Primary Code | 042 |
Goods codes | |
CC0000 | Color is not claimed as a feature of the mark. |
GS0051 | Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides |
GS0421 | Testing, inspection or research of pharmaceuticals; providing medical research information in the field of pharmaceuticals |
INTERNATIONAL REGISTRATION | |
International Registration Number | 1091455 |
---|---|
International Registration Date | 07/22/2011 |
International Publication Date | 10/13/2011 |
International Renewal Date | 07/22/2021 |
Auto protection | 04/06/2013 |
International Status Code | 001 - Request for extension of protection established |
International Status Date | 10/06/2011 |
Priority Claimed In | No |
First Refusal In | Yes |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
04/04/2012 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
04/03/2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
04/03/2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
11/20/2011 | REFUSAL PROCESSED BY IB | P | RFNT - REFUSAL PROCESSED BY IB | |
10/28/2011 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | P | RFCS - REFUSAL SENT TO IB | |
10/28/2011 | REFUSAL PROCESSED BY MPU | P | RFRR | |
10/28/2011 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | E | RFCR - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | |
10/27/2011 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
10/27/2011 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
10/14/2011 | APPLICATION FILING RECEIPT MAILED | O - Outgoing Correspondence | MAFR | |
10/10/2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
10/07/2011 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | I - Incoming Correspondence | LIMI | |
10/06/2011 | SN ASSIGNED FOR SECT 66A APPL FROM IB | M | REPR - SN ASSIGNED FOR SECT 66A APPL FROM IB |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.